ISIN | CH0010211107 |
---|---|
Valor Number | 1021110 |
Bloomberg Global ID | BBG000C6QQH8 |
Fund Name | Credit Suisse (CH) Privilege 45 CHF A |
Fund Provider |
UBS Asset Management Switzerland AG, Zurich
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Asset Management Switzerland AG, Zurich |
Representative in Switzerland | |
Distributor(s) | |
Asset Class | Asset Allocation |
EFC Category | |
Distribution Policy | Distribution |
Home Country | Switzerland |
Issuing Condition | The fund management company and/or distributor charges an issuing commission (different commissions can be charged for the same fund depending on the sales channel) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | The Fund invests in equities, bonds, and money market instruments worldwide. In so doing, it adheres to the provisions of the Federal Law on Occupational Old Age, Survivors and Disability Pension Plans (BVG) and the relevant regulations (BVV2 and BVV3) governing investments. The Fund distributes its earnings. |
Peculiarities |
Current Price * | 133.61 CHF | 05.06.2025 |
---|---|---|
Previous Price * | 133.70 CHF | 04.06.2025 |
52 Week High * | 137.21 CHF | 13.02.2025 |
52 Week Low * | 125.57 CHF | 07.04.2025 |
NAV * | 133.61 CHF | 05.06.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 1,161,772,162 | |
Unit/Share Assets *** | 155,587,992 | |
Trading Information SIX |
YTD Performance | +0.26% |
30.12.2024 - 05.06.2025
30.12.2024 05.06.2025 |
---|---|---|
1 month | +1.50% |
05.05.2025 - 05.06.2025
05.05.2025 05.06.2025 |
3 months | -1.55% |
05.03.2025 - 05.06.2025
05.03.2025 05.06.2025 |
6 months | -0.40% |
05.12.2024 - 05.06.2025
05.12.2024 05.06.2025 |
1 year | +2.60% |
05.06.2024 - 05.06.2025
05.06.2024 05.06.2025 |
2 years | +8.42% |
05.06.2023 - 05.06.2025
05.06.2023 05.06.2025 |
3 years | +4.94% |
07.06.2022 - 05.06.2025
07.06.2022 05.06.2025 |
5 years | +9.58% |
05.06.2020 - 05.06.2025
05.06.2020 05.06.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
UBS MSCI USA Selection ETF USD acc | 8.97% | |
---|---|---|
UBS S&P 500 Scrd & Scrn ETF USD acc | 4.98% | |
Nestle SA | 3.22% | |
Novartis AG Registered Shares | 2.85% | |
UBS (CH) IF - Eq CH All ESG NSL I-A-acc | 2.75% | |
Roche Holding AG | 2.55% | |
UBS MSCI EM Sel IndexF USD QX acc | 2.35% | |
CSIMF Swiss Real Estate Securities EB | 1.50% | |
Graham Macro UCITS J Platform USD | 1.43% | |
UBS MSCI Japan Sel Index Fd JPY QX acc | 1.39% | |
Last data update | 30.04.2025 |
TER | 1.40% |
---|---|
TER date | 31.12.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 1.60% |
Ongoing Charges *** | 1.40% |
SRRI ***
|
|
SRRI date *** | 30.04.2025 |